RecallDepth
Class II Terminated

Minivelle (estradiol transdermal system) 0.1 mg/day, 1 System per pouch (NDC 68968-6610-1), packaged in 8 pouches per box (NDC 68968-6610-8), Rx only, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186; Dist. by: Noven Therapeutics, LLC, Miami, Florida 33186.

This recall has been terminated (originally issued May 16, 2018).

Company
Noven Pharmaceuticals, Inc.
Recall Initiated
May 4, 2018
Posted
May 16, 2018
Recall Number
D-0862-2018
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
61960 boxes
Firm Location
Miami, FL, United States
Official Source
View on FDA website ↗

Reason for Recall

Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

Distribution

Nationwide in the USA.

Lot / Code Info

Lot #: 81391, 81638 Exp. 10/18

More recalls by Noven Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class II Drug recalls